Skip to main content
Premium Trial:

Request an Annual Quote

ABI s DNA-Sequencing Disclosure Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Oct. 3 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 30.

 

1. ABI, Breaking Silence, Says It Is Working on Next-Generation Sequencing Technologies (from Sept. 29)

2. ABI and Promega Settle Litigation Over PCR Technology (from Sept. 26)

3. Affy Warns that Low Manufacturing Yields Will Lead to $10M-12M Shortfall in Q3 Revenues (from Sept. 28)

4. Court Permanently Bars Stratagene from Selling FullVelocity Products; Company Vows to Appeal (from Sept. 30)

5. Investment Bank Upgrades Affy Stock In Wake of Expected Revenue Shortfall (from Sept. 28)

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.